Scottmtb...I certainly don't know how many startup biotechs you have been invested in, but most of them DON'T make it. It is amazing we are still alive and have irons in the fire. It's normally a lack of cash that brings them down. We have certainly had our share of major mistakes, but we still are in the race.

ESS is not a fluke, and MANF is offering a tremendous advance in the fight on RP.

Aloha, BsR